25 employees
NephroSant’s mission is to deliver new diagnostic tools for early detection and lifetime monitoring of kidney health and injury.
2017
$16M
from 2 investors over 2 rounds
Nephrosant, Inc. raised $16M on March 16, 2021
Investors: DaVita Venture Group and DigitalDx Ventures